Gary Blackburn

Chief Executive Officer

Claremont BioSolutions, LLC

United States

Professional Summary

Dr. Gary Blackburn, Chief Executive Officer for Claremont BioSolutions (www.ClaremontBio.com) leads a cutting edge, a privately held, emerging growth technology company, bringing over 25 years of R&D and medical technology experience within the microbiology field. With his deep foundational experience across the emerging growth biotechnology industry, Dr. Blackburn provides leadership and drives the knowledge and discovery process across a broad range of medical niche specialties including sample preparation and the inherent challenges therein with regard to acquiring difficult sample types, the development of unique proprietary reagents and buffers that are of broad interest in the diagnostics industry, as well as micro motor mechanical technologies to increase efficiencies in sample intake procedures. Under Dr. Blackburn’s guidance and supervision, the privately held company has, among other notable and cutting edge achievements, developed proprietary disposable devices that employ micro-motors to perform highly efficient mechanical tissue homogenization, and nucleic acid extraction.

Skills

Specialization

DNA Diagnostics; Emerging growth biotechnology; Research and development; IGEN International Inc